Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella Typhimurium: A possible adjunct therapy

Annals of Clinical Microbiology and Antimicrobials

Volumn 10, Issue , 2011, Pages

  Rishi, Praveen ^a   Preet, Simran ^a   Kaur, Prabhjot ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALEXIN; CEFOXITIN; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; GENTAMICIN; NITRITE; NORFLOXACIN; PROBIOTIC AGENT; TETRACYCLINE; ANTIINFECTIVE AGENT; BIOLOGICAL FACTOR;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CELL FREE SYSTEM; CELL FUNCTION; COMBINATION CHEMOTHERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISK DIFFUSION; DRUG EFFICACY; DRUG POTENTIATION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LIPID PEROXIDATION; MACROPHAGE; MICROTITER PLATE ASSAY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALMONELLA TYPHIMURIUM; SUPERNATANT; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; HUMAN; MICROBIOLOGY; MOUSE; PERITONEUM MACROPHAGE; SALMONELLOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL FACTORS; CELLS, CULTURED; DRUG SYNERGISM; HUMANS; LACTOBACILLUS PLANTARUM; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; PROBIOTICS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 79951952872     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-10-9     Document Type: Article

References (36)

1. Henderson DK, Levy SB, . editors Resistant organisms: global impact on continuum of care. International Congress and Symposium Series #220 1997, New York, NY: Royal Society of Medicine, editors.
2. Birosova L, Mikulasova M. Development of triclosan and antibiotic resistance in Salmonella enterica serovar Typhimurium. J Med Microbiol 2009, 58(4):436-41. 10.1099/jmm.0.003657-0, 19273638.
3. Hammad AM, Shimamato T. Towards a compatible probiotic-antibiotic therapy: assessment of antimicrobial resistance in the Japanese probiotics. J Appl Microbiol 2010, 109(4):1349-13603. 10.1111/j.1365-2672.2010.04762.x, 20497275.
4. Ibezim EC, Esimore CO, Obodo CE, Nnamani PO, Brown SA, Onyishi IV. A study of the in-vitro interaction of co-trimoxazole and ampicillin using the checker board method. Afr J Biotechnol 2006, 5(13):1284-1288.
5. Truusalu K, Mikelsaar RH, Naaber P, Karki T, Kullisaar T, Zilmer M, et al. Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiol 2008, 8:132. 10.1186/1471-2180-8-132, 2518159, 18680567.
6. Bergonzelli GE, Blum S, Brussow H, Theulaz CI. Probiotics as a treatment strategy for gastrointestinal diseases. Digestion 2005, 72:57-68. 10.1159/000087638, 16113543.
7. Rishi P, Mavi SK, Bharrhan S, Shukla G, Tewari R. Protective efficacy of probiotics alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiol Ecol 2009, 69:222-230. 10.1111/j.1574-6941.2009.00703.x, 19496820.
8. Rishi P, Kaur S, Bhalla MPS, Preet S, Tiwari RP. Selection of probiotic Lactobacillus acidophilus and its prophylactic activity against murine Salmonellosis. Int J Pro Pre 2008, 3(2):89-98.
9. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001, 73:430-436.
10. Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med 2005, 257:78-92. 10.1111/j.1365-2796.2004.01410.x, 15606379.
11. Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr 2006, 42:454-475. 10.1097/01.mpg.0000221913.88511.72, 16707966.
12. Zou J, Dong J, Yu X. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter 2009, 14:97-107.
13. Rybak JM, Grath MJB. Combination antimicrobial therapy for bacterial infections, Guidelines for the Clinician. Drugs 1996, 52(3):390-402. 10.2165/00003495-199652030-00005, 8875129.
14. Preet S, Verma I, Rishi P. Cryptdin-2: a novel therapeutic agent for experimental Salmonella Typhimurium infection. J Antimicrob Chemother 2010, 65:991-994. 10.1093/jac/dkq066, 20228082.
15. Piddock LJV, Ricci V, McLaren I, Griggs DJ. Role of mutation in the gyrA and par C genes of nalidixic-acid resistant Salmonella serotypes isolated from animals in the United Kingdom. J Antimicrob Chemother 1998, 41:635-641. 10.1093/jac/41.6.635, 9687102.
16. Bauer AW, Kirby MM, Sherris JC, Tuurck M. Antimicrobial susceptibility testing by a standardised single disc method. Am J Clin Path 1966, 45:493-496.
17. NCCLS (National Committee for clinical laboratory standards) NCCLS document M-100-S9, Performance standards for antimicrobial susceptibility testing, 9th information supplement. NCCLS: Wayne Pa, NCCLS (National Committee for clinical laboratory standards).
18. Tagg JR, McGiven AR. Assay system for bacteriocins. Appl Microbiol 1971, 21:943-948. 377313, 4930039.
19. Ogunbanwo ST, Sanni AI, Onilude AA. Characterization of bacteriocin produced by Lactobacillus plantarum F1 and Lactobacillus brevis OG1. Afr J Biotechnol 2003, 2(8):219-227.
20. He L, Chen W. Synergetic activity of nisin with cell-free supernatant of Bacillus licheniformis ZJU12 against food borne bacteria. Food Res Int 2006, 39:905-909.
21. White RL, Burgess DS, Manduru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 1996, 40:1914-1918. 163439, 8843303.
22. Chanana V, Majumdar S, Rishi P. Tumour necrosis factor alpha mediated apoptosis in murine macrophages by Salmonella enterica serovar Typhi under oxidative stress. FEMS Immuno Med Microbiol 2006, 47:278-286.
23. Lowry OH, Rosbrough NJ, Farr AL, Randall RJ. Protein estimation with Folin's reagent. J Biol Chem 1951, 193:265-275.
24. Green LC, Wagner DA, Glogowski J, Shipper PL, Wishnok J, Raannerbaun SR. Analysis of nitrate, nitrite and 15N nitrate in biological fluids. Anal Biochem 1982, 126:121-158.
25. Chanana V, Ray P, Rishi DB, Rishi P. Reactive nitrogen intermediates and monokines induce caspase-3 mediated macrophage apoptosis by anaerobically stressed Salmonella typhi. Clin Exp Immunol 2007, 150(2):368-374. 10.1111/j.1365-2249.2007.03503.x, 2219343, 17888027.
26. Mandomando I, Macete E, Sigauque B, Morais L, Quinto L, Sacarlal J, et al. Invasive non-typhoidal Salmonella in Mozambican children. Trop Med Int Health 2009, 14(12):1467-74. 10.1111/j.1365-3156.2009.02399.x, 19793081.
27. Mengo DM, Kariuk S, Muigai AWT, Revathi GN. Trends in Salmonella enterica serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010, 4(6):393-396.
28. Singh BR, Jyoti J, Chandra M, Babu N, Sharma GJ. Drug resistance patterns of Salmonella isolates of equine origin from India. J Infect Dev Ctries 2009, 3(2):141-147. 10.3855/jidc.61, 19755745.
29. Botes M, Loos B, van Reenen CA, Dicks LM. Adhesion of the probiotic strains Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments. Arch Microbiol 2008, 190(5):573-84. 10.1007/s00203-008-0408-0, 18641972.
30. Gopal PK, Prasad J, Smart J, Gill HS. In-vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int J Food Microbiol 2001, 67(3):207-16. 10.1016/S0168-1605(01)00440-8, 11518430.
31. Lee I, Turner M, Lee CC. Acute patchy exanthematous pustulosis caused by sulfamethoxazole-trimethoprim. J Am Acad Dermatol 2010, 63(2):41-43.
32. Rosenberger CM, Gallo RL, Finalay BB. Interplay between antibacterial effcetors: A macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci 2004, 101(8):2422-2427. 10.1073/pnas.0304455101, 356966, 14983025.
33. Hatcher GE, Lambrecht RS. Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J Dairy Sci 1993, 76:2485-2492. 10.3168/jds.S0022-0302(93)77583-9, 8227651.
34. Vincenti JE. The influence of cell-free Lactobacillus rhamnosus GG supernatant on the phagocytic activity of macrophages. Bio Horizons 2010, 3(2):105-112.
35. Lin MY, Yen CL. Inhibition of lipid peroxidation by Lactobacillus acidophilus and Bifidobacterium longum. J Agr Food Chem 1999, 47(9):3661-3664.
36. Madsen K, Cornish A, Soper P, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterol 2001, 121:580-581.